This is a Study to Evaluate the Safety, Tolerability, PK and PD of IV Administered ABL301 in Healthy Adult Participants

NCT05756920 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ABL301
DRUG: Placebo

Sponsor

ABL Bio, Inc.